Management of medication overuse (MO) and medication overuse headache (MOH) S1 guideline

INTRODUCTION: Chronic headache due to the overuse of medication for the treatment of migraine attacks has a prevalence of 0.5–2.0%. This guideline provides guidance for the management of medication overuse (MO) and medication overuse headache (MOH). RECOMMENDATIONS: Treatment of headache due to over...

Descripción completa

Detalles Bibliográficos
Autores principales: Diener, Hans-Christoph, Kropp, Peter, Dresler, Thomas, Evers, Stefan, Förderreuther, Stefanie, Gaul, Charly, Holle-Lee, Dagny, May, Arne, Niederberger, Uwe, Moll, Sabrina, Schankin, Christoph, Lampl, Christian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Guidelines
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422154/
https://www.ncbi.nlm.nih.gov/pubmed/36031642
http://dx.doi.org/10.1186/s42466-022-00200-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422154/
https://www.ncbi.nlm.nih.gov/pubmed/36031642
http://dx.doi.org/10.1186/s42466-022-00200-0

Ejemplares similares